Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pioglitazone × 30 days × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Liposarcoma, Myxoid 1 Liposarcoma 1

Interventions

Specimen Handling 151 Magnetic Resonance Spectroscopy 125 Biopsy 95 pembrolizumab 90 Cyclophosphamide 72 Carboplatin 69 Paclitaxel 58 Cisplatin 58 Nivolumab 49 venetoclax 45 Radiotherapy 40 durvalumab 36 Gemcitabine 36 fludarabine 35 Rituximab 34 Dexamethasone 34 olaparib 33 Radiation 32 Bevacizumab 32 atezolizumab 31 Prednisone 30 Oxaliplatin 30 X-Rays 28 Ipilimumab 27 Fluorouracil 27 Docetaxel 27 Cytarabine 27 Lenalidomide 26 Etoposide 26 Azacitidine 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡